The therapeutic outcomes of patients with acromegaly since 2000

被引：0
|
作者：
Fukuda, Izumi [1 ]
Hiduka, Naomi [1 ]
Kurimoto, Makiko [1 ]
Morita, Junko [1 ]
Tanaka, Satoshi [1 ]
Yamakado, Yu [1 ]
Sata, Akira [1 ]
Takano, Kazue [1 ]
机构：
[1] Tokyo Womens Med Univ, Dept Med, Inst Clin Endocrinol, Tokyo, Japan
来源：
ENDOCRINE JOURNAL | 2010年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [21] Evolving therapeutic strategies for acromegaly
    Darzy, KH
    Shalet, SM
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (06) : 468 - 471
  • [22] New therapeutic agents for acromegaly
    Shlomo Melmed
    Nature Reviews Endocrinology, 2016, 12 : 90 - 98
  • [23] New therapeutic agents for acromegaly
    Melmed, Shlomo
    NATURE REVIEWS ENDOCRINOLOGY, 2016, 12 (02) : 90 - 98
  • [24] Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
    Pascual-Corrales, Eider
    Biagetti, Betina
    Marazuela, Monica
    Asensio-Wandosel, Diego
    Berrocal, Victor Rodriguez
    Echarri, Ana Irigaray
    Novo-Rodriguez, Cristina
    Calatayud, Maria
    Bernabeu, Ignacio
    Alvarez-Escola, Cristina
    Tenorio-Jimenez, Carmen
    Molero, Inmaculada Gonzalez
    Iglesias, Pedro
    Blanco, Concepcion
    de Miguel, Paz
    Mezquita, Elena Lopez
    Lamas, Cristina
    Aulinas, Anna
    Gracia, Paola
    Recio-Cordova, Jose Maria
    Sampedro-Nunez, Miguel
    Paja, Miguel
    Rodriguez, Maria Dolores Moure
    Fajardo-Montanana, Carmen
    Cordido, Fernando
    Torre, Edelmiro Menendez
    Percovich, Juan Carlos
    Garcia-Centeno, Rogelio
    Camara, Rosa
    Hanzu, Felicia Alexandra
    Delgado, Almudena Vicente
    Fernandez, Laura Gonzalez
    Guerrero-Perez, Fernando
    Garcia-Agullo, Maria Dolores Ollero
    Novoa-Testa, Iria
    Villar-Taibo, Rocio
    Valderrama, Pamela Benitez
    Galiana, Pablo Abellan
    Moreno, Eva Venegas
    De Lara, Fernando Vidal-Ostos
    Ensenat, Joaquim
    Aznar, Silvia
    Asla, Queralt
    Aviles-Perez, Maria Dolores
    Puig-Domingo, Manel
    Araujo-Castro, Marta
    PITUITARY, 2024, 27 (05) : 497 - 506
  • [25] CHOLELITHIASIS AND ACROMEGALY - THERAPEUTIC STRATEGIES
    MONTINI, M
    GIANOLA, D
    PAGANI, MD
    PEDRONCELLI, A
    CALDARA, R
    GHERARDI, F
    BONELLI, M
    LANCRANJAN, I
    PAGANI, G
    CLINICAL ENDOCRINOLOGY, 1994, 40 (03) : 401 - 406
  • [26] Morphometric changes correlate with poor psychological outcomes in patients with acromegaly
    Imran, Syed Ali
    Tiemensma, Jitske
    Kaiser, Stephanie M.
    Vallis, Michael
    Doucette, Steve
    Abidi, Ebad
    Yip, Churn-Ern
    De Tugwell, Barna
    Siddiqi, Ferhan
    Clarke, David B.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 174 (01) : 41 - 50
  • [27] Tamoxifen as a therapeutic agent in acromegaly
    Irida Balili
    Ariel Barkan
    Pituitary, 2014, 17 : 500 - 504
  • [28] BROMOCRIPTINE AND ACROMEGALY - THERAPEUTIC IMPLICATIONS
    BROOKS, AP
    NAIRN, IM
    STEPHEN, PJ
    STRONG, JA
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1979, 72 (08) : 562 - 564
  • [29] Evolving therapeutic strategies for acromegaly
    K. H. Darzy
    S. M. Shalet
    Journal of Endocrinological Investigation, 2001, 24 : 468 - 471
  • [30] Predicting Outcomes of Acromegaly Patients: Studies from the Third World
    Amirjamshidi, Abbas
    Abbasioun, Kazem
    WORLD NEUROSURGERY, 2014, 81 (01) : E3 - E4
12345